biostudies-literatureMoyes KWSteven Higgins Brain Tumor Research FundSponsored Research Agreement Bristol Myers Squibbe1507668https://www.ebi.ac.uk/biostudies/studies/S-EPMC6204983biostudies-literatureUnknown7(11)Efforts to reduce immunosuppression in the solid tumor microenvironment by blocking the recruitment or polarization of tumor associated macrophages (TAM), or myeloid derived suppressor cells (MDSCs), have gained momentum in recent years. Expanding our knowledge of the immune cell types, cytokines, or recruitment factors that are associated with high-grade disease, both within the tumor and in circulation, is critical to identifying novel targets for immunotherapy. Furthermore, a better understanding of how therapeutic regimens, such as Dexamethasone (Dex), chemotherapy, and radiation, impact these factors will facilitate the design of therapies that can be targeted to the appropriate populations and retain efficacy when administered in combination with standard of care regimens. Here we peOncoimmunologyEffects of tumor grade and dexamethasone on myeloid cells in patients with glioma.PMC6204983N/ACarleton MOCrane CAFranco SHoglund VGonzalez-Cuyar LFHaberthur KMoyes KWKreuser SAEllenbogen RGSilber JGilbertson DGSimmons RWinter CLocke DDeutsch GHDavis ALieberman NAfalseEffects of tumor grade and dexamethasone on myeloid cells in patients with glioma.Efforts to reduce immunosuppression in the solid tumor microenvironment by blocking the recruitment or polarization of tumor associated macrophages (TAM), or myeloid derived suppressor cells (MDSCs), have gained momentum in recent years. Expanding our knowledge of the immune cell types, cytokines, or recruitment factors that are associated with high-grade disease, both within the tumor and in circulation, is critical to identifying novel targets for immunotherapy. Furthermore, a better understanding of how therapeutic regimens, such as Dexamethasone (Dex), chemotherapy, and radiation, impact these factors will facilitate the design of therapies that can be targeted to the appropriate populations and retain efficacy when administered in combination with standard of care regimens. Here we pe2018-01-01T00:00:00Z20182026-04-15T03:17:26.257Z2019-03-27T00:05:35ZS-EPMC62049833037757010.1080/2162402X.2018.1507668